Global Brucellosis Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2112240253 | Category: Pharma & Healthcare | Pages: 114 | Format: PDF | Published Date: October 17,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Brucellosis Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Brucellosis Vaccines market size is estimated to be worth US$ 11 million in 2021 and is forecast to a readjusted size of USD 14 million by 2028 with a CAGR of 3.5% during review period. Cattle accounting for % of the Brucellosis Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While S19 Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Brucellosis Vaccines include Jinyu, Colorado Serum, Boehringer Ingelheim, Biogenesis-Bago, and Vetal Company, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Brucellosis Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    S19 Vaccine
    RB51 Vaccine Strain
Market segment by Application can be divided into
    Cattle
    Sheep
    Others
The key market players for global Brucellosis Vaccines market are listed below:
    Jinyu
    Colorado Serum
    Boehringer Ingelheim
    Biogenesis-Bago
    Vetal Company
    CZ Veterinaria
    SYVA Laboratorios
    Indian Immunologicals
    Qilu
    Tecnovax
    Hester Biosciences
    Zoetis
    Onderstepoort Biological
    Instituto Rosenbusch
    Ceva Sante Animale
    Calier & Biologicos Laverlam
    Biovet
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Brucellosis Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Brucellosis Vaccines, with price, sales, revenue and global market share of Brucellosis Vaccines from 2019 to 2022.
Chapter 3, the Brucellosis Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Brucellosis Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Brucellosis Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Brucellosis Vaccines.
Chapter 13, 14, and 15, to describe Brucellosis Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Brucellosis Vaccines Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Brucellosis Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 S19 Vaccine
        1.2.3 RB51 Vaccine Strain
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Brucellosis Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Cattle
        1.3.3 Sheep
        1.3.4 Others
    1.4 Global Brucellosis Vaccines Market Size & Forecast
        1.4.1 Global Brucellosis Vaccines Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Brucellosis Vaccines Sales in Volume (2017-2028)
        1.4.3 Global Brucellosis Vaccines Price (2017-2028) 
    1.5 Global Brucellosis Vaccines Production Capacity Analysis
        1.5.1 Global Brucellosis Vaccines Total Production Capacity (2017-2028)
        1.5.2 Global Brucellosis Vaccines Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Brucellosis Vaccines Market Drivers
        1.6.2 Brucellosis Vaccines Market Restraints
        1.6.3 Brucellosis Vaccines Trends Analysis
2 Manufacturers Profiles
    2.1 Jinyu
        2.1.1 Jinyu Details
        2.1.2 Jinyu Major Business
        2.1.3 Jinyu Brucellosis Vaccines Product and Services
        2.1.4 Jinyu Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Colorado Serum
        2.2.1 Colorado Serum Details
        2.2.2 Colorado Serum Major Business
        2.2.3 Colorado Serum Brucellosis Vaccines Product and Services
        2.2.4 Colorado Serum Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Boehringer Ingelheim
        2.3.1 Boehringer Ingelheim Details
        2.3.2 Boehringer Ingelheim Major Business
        2.3.3 Boehringer Ingelheim Brucellosis Vaccines Product and Services
        2.3.4 Boehringer Ingelheim Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Biogenesis-Bago
        2.4.1 Biogenesis-Bago Details
        2.4.2 Biogenesis-Bago Major Business
        2.4.3 Biogenesis-Bago Brucellosis Vaccines Product and Services
        2.4.4 Biogenesis-Bago Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Vetal Company
        2.5.1 Vetal Company Details
        2.5.2 Vetal Company Major Business
        2.5.3 Vetal Company Brucellosis Vaccines Product and Services
        2.5.4 Vetal Company Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 CZ Veterinaria
        2.6.1 CZ Veterinaria Details
        2.6.2 CZ Veterinaria Major Business
        2.6.3 CZ Veterinaria Brucellosis Vaccines Product and Services
        2.6.4 CZ Veterinaria Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 SYVA Laboratorios
        2.7.1 SYVA Laboratorios Details
        2.7.2 SYVA Laboratorios Major Business
        2.7.3 SYVA Laboratorios Brucellosis Vaccines Product and Services
        2.7.4 SYVA Laboratorios Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Indian Immunologicals
        2.8.1 Indian Immunologicals Details
        2.8.2 Indian Immunologicals Major Business
        2.8.3 Indian Immunologicals Brucellosis Vaccines Product and Services
        2.8.4 Indian Immunologicals Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Qilu
        2.9.1 Qilu Details
        2.9.2 Qilu Major Business
        2.9.3 Qilu Brucellosis Vaccines Product and Services
        2.9.4 Qilu Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Tecnovax
        2.10.1 Tecnovax Details
        2.10.2 Tecnovax Major Business
        2.10.3 Tecnovax Brucellosis Vaccines Product and Services
        2.10.4 Tecnovax Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Hester Biosciences
        2.11.1 Hester Biosciences Details
        2.11.2 Hester Biosciences Major Business
        2.11.3 Hester Biosciences Brucellosis Vaccines Product and Services
        2.11.4 Hester Biosciences Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Zoetis
        2.12.1 Zoetis Details
        2.12.2 Zoetis Major Business
        2.12.3 Zoetis Brucellosis Vaccines Product and Services
        2.12.4 Zoetis Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.13 Onderstepoort Biological
        2.13.1 Onderstepoort Biological Details
        2.13.2 Onderstepoort Biological Major Business
        2.13.3 Onderstepoort Biological Brucellosis Vaccines Product and Services
        2.13.4 Onderstepoort Biological Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.14 Instituto Rosenbusch
        2.14.1 Instituto Rosenbusch Details
        2.14.2 Instituto Rosenbusch Major Business
        2.14.3 Instituto Rosenbusch Brucellosis Vaccines Product and Services
        2.14.4 Instituto Rosenbusch Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.15 Ceva Sante Animale
        2.15.1 Ceva Sante Animale Details
        2.15.2 Ceva Sante Animale Major Business
        2.15.3 Ceva Sante Animale Brucellosis Vaccines Product and Services
        2.15.4 Ceva Sante Animale Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.16 Calier & Biologicos Laverlam
        2.16.1 Calier & Biologicos Laverlam Details
        2.16.2 Calier & Biologicos Laverlam Major Business
        2.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Product and Services
        2.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.17 Biovet
        2.17.1 Biovet Details
        2.17.2 Biovet Major Business
        2.17.3 Biovet Brucellosis Vaccines Product and Services
        2.17.4 Biovet Brucellosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Brucellosis Vaccines Breakdown Data by Manufacturer
    3.1 Global Brucellosis Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Brucellosis Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Brucellosis Vaccines
    3.4 Market Concentration Rate
        3.4.1 Top 3 Brucellosis Vaccines Manufacturer Market Share in 2021
        3.4.2 Top 6 Brucellosis Vaccines Manufacturer Market Share in 2021
    3.5 Global Brucellosis Vaccines Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Brucellosis Vaccines Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Brucellosis Vaccines Market Size by Region
        4.1.1 Global Brucellosis Vaccines Sales in Volume by Region (2017-2028)
        4.1.2 Global Brucellosis Vaccines Revenue by Region (2017-2028)
    4.2 North America Brucellosis Vaccines Revenue (2017-2028)
    4.3 Europe Brucellosis Vaccines Revenue (2017-2028)
    4.4 Asia-Pacific Brucellosis Vaccines Revenue (2017-2028)
    4.5 South America Brucellosis Vaccines Revenue (2017-2028)
    4.6 Middle East and Africa Brucellosis Vaccines Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Brucellosis Vaccines Sales in Volume by Type (2017-2028)
    5.2 Global Brucellosis Vaccines Revenue by Type (2017-2028)
    5.3 Global Brucellosis Vaccines Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Brucellosis Vaccines Sales in Volume by Application (2017-2028)
    6.2 Global Brucellosis Vaccines Revenue by Application (2017-2028)
    6.3 Global Brucellosis Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Brucellosis Vaccines Sales by Type (2017-2028)
    7.2 North America Brucellosis Vaccines Sales by Application (2017-2028)
    7.3 North America Brucellosis Vaccines Market Size by Country
        7.3.1 North America Brucellosis Vaccines Sales in Volume by Country (2017-2028)
        7.3.2 North America Brucellosis Vaccines Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Brucellosis Vaccines Sales by Type (2017-2028)
    8.2 Europe Brucellosis Vaccines Sales by Application (2017-2028)
    8.3 Europe Brucellosis Vaccines Market Size by Country
        8.3.1 Europe Brucellosis Vaccines Sales in Volume by Country (2017-2028)
        8.3.2 Europe Brucellosis Vaccines Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Brucellosis Vaccines Sales by Type (2017-2028)
    9.2 Asia-Pacific Brucellosis Vaccines Sales by Application (2017-2028)
    9.3 Asia-Pacific Brucellosis Vaccines Market Size by Region
        9.3.1 Asia-Pacific Brucellosis Vaccines Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Brucellosis Vaccines Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Brucellosis Vaccines Sales by Type (2017-2028)
    10.2 South America Brucellosis Vaccines Sales by Application (2017-2028)
    10.3 South America Brucellosis Vaccines Market Size by Country
        10.3.1 South America Brucellosis Vaccines Sales in Volume by Country (2017-2028)
        10.3.2 South America Brucellosis Vaccines Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Brucellosis Vaccines Sales by Type (2017-2028)
    11.2 Middle East & Africa Brucellosis Vaccines Sales by Application (2017-2028)
    11.3 Middle East & Africa Brucellosis Vaccines Market Size by Country
        11.3.1 Middle East & Africa Brucellosis Vaccines Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Brucellosis Vaccines Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Brucellosis Vaccines and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Brucellosis Vaccines
    12.3 Brucellosis Vaccines Production Process
    12.4 Brucellosis Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Brucellosis Vaccines Typical Distributors
    13.3 Brucellosis Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Brucellosis Vaccines Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?